{
    "Trade/Device Name(s)": [
        "Cepheid Xpert Respiratory Control Panel"
    ],
    "Submitter Information": "Microbiologics, Inc.",
    "510(k) Number": "K190086",
    "Predicate Device Reference 510(k) Number(s)": [
        "K182472"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PMN"
    ],
    "Summary Letter Date": "September 12, 2019",
    "Summary Letter Received Date": "September 13, 2019",
    "Submission Date": "September 19, 2019",
    "Regulation Number(s)": [
        "21 CFR 866.3920"
    ],
    "Regulation Name(s)": [
        "Assayed quality control material for clinical microbiology assays"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza A (H1N1) virus",
        "Influenza A (H3N2) virus",
        "Influenza B virus",
        "Respiratory Syncytial Virus A",
        "Coxsackie virus B1"
    ],
    "Specimen Type(s)": [],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Cepheid GeneXpert Instrument System"
    ],
    "Method(s)/Technology(ies)": [
        "RNA extraction",
        "Amplification",
        "Detection"
    ],
    "Methodologies": [
        "Nucleic acid testing procedures"
    ],
    "Submission Type(s)": [
        "Quality control material",
        "Panel"
    ],
    "Document Summary": "FDA 510(k) summary for Cepheid Xpert Respiratory Control Panel used as external assayed controls for molecular detection of respiratory viruses with the Cepheid Xpert Xpress Flu/RSV assay",
    "Indications for Use Summary": "Intended as external assayed positive and negative quality controls to monitor performance of nucleic acid testing for qualitative detection of Influenza A (H1N1 and H3N2), Influenza B, and RSV A with the Cepheid Xpert Xpress Flu/RSV assay on the GeneXpert Instrument System",
    "fda_folder": "Microbiology"
}